低分子肝素钙联合银杏达莫治疗慢性肺源性心脏病急性发作的疗效观察

Efficacy of Low Molecular Heparin Combined with Ginkgo Leaf Injection for Acute Exacerbations of Chronic Pulmonary Disease

目的:探讨低分子肝素钙联合银杏达莫注射液治疗慢性肺源性心脏病急性发作的临床疗效。方法:56例慢性肺源性心脏病患者随机分为治疗组合对照组,每组各28例;对照组给予吸氧、抗感染、止咳平喘、强心、利尿、扩血管等常规治疗,治疗组在对照组治疗基础上给予低分子肝素钙注射液皮下注射,并联合银杏达莫注射液静滴,治疗7天后评价疗效。结果:治疗组有效率达82.1%,显著高于对照组(53.6%),差异有统计学意义(P<0.05);动脉血气分析结果及血粘度在治疗前无明显差异,治疗后均明显改善,治疗组较对照组差异有统计学意义(P<0.05)。结论:低分子肝素钙联合银杏达莫注射液治疗慢性肺源性心脏病急性发作安全有效。

Objective：To investigate the effectiveness and safety of Low Molecular Heparin combined with Ginkgo Leaf Injection for acute exacerbations of chronic pulmonary disease.Methods：56 cases of chronic pulmonary heart disease were randomly divided ino treatment group and control group,28 cases for each group.The control group：conventional treatments;the treatment group： Low Molecular Heparin combined with Ginkgo Leaf Injection.Results：The effective rate was 82.1% in treatment group,was significantly higher than control group（P0.05）.Before treatment,there was no significance difference between the two groups in arterial blood-gas analysis and blood rheology,while after treatment,the difference is significance（P0.05）.Conclusion：Low Molecular Heparin combined with Ginkgo Leaf Injection for acute exacerbations of chronic pulmonary disease is effective and safety.